FGF-9
FGF-9, originally purified as glia-activating factor from rat brain conditioned medium, binds FGFR2c and FGFR3c with preference and is expressed in brain, lung, gonad and synovium. In the developing lung it promotes mesenchymal proliferation and branching morphogenesis; in the gonad it supports testis cord formation; and in the adult joint it contributes to synovial inflammation in rheumatoid arthritis. FGF9 is upregulated in lung adenocarcinoma and in endometriotic lesions. Its survival-promoting action on dopaminergic and motor neurons makes it a candidate neuroprotective factor. Recombinant FGF-9 is used in these disease models and for FGFR3c-selective signaling studies.
-
FGF-9 Protéines Recombinantes (8)
- Species:
- Source:
- Species:
- Source:
- Species:
- Source:
- Species:
- Source:
- Species:
- Source:
- Species:
- Source:
- Species:
- Source:
- Species:
- Source:
Recombinant Protein Expression Service
- Codon Optimization
- Gene Synthesis
- Construction of Expression Vector
- Strain Screening
- Protein Expression
- Purification & QC
- Protein Delivery
- Formule: Human
- Masse moléculaire: Sf9 insect cells
The EpCAM/TROP1 protein serves as an important homogeneous interacting molecule that promotes direct contact between intestinal epithelial cells (IEC) and intraepithelial lymphocytes (IEL) in the mucosal epithelium. This feature helps establish an immune barrier against mucosal infections. EpCAM/TROP1 Protein, Human (His-SUMO) is the recombinant human-derived EpCAM/TROP1 protein, expressed by E. coli , with N-6*His, N-SUMO labeled tag.
